Using administrative health data to ascertain ovarian cancer treatment information in Australia: a validation against medical records
Open Access
- 14 September 2026
- journal article
- Published by CSIRO Publishing in Public Health Research and Practice
- Vol. 36 (3)
Abstract
Objectives: Understanding patterns of cancer care is important for improving patient safety and reducing inequity. Linked administrative datasets offer a cost-efficient alternative to medical chart abstraction, but the information may not be as comprehensive and accurate. Our aim was to determine the validity of using linked administrative data to identify ovarian cancer primary treatment in Australia, using data from medical charts for comparison. Methods: We used data from the Ovarian cancer Prognosis And Lifestyle study, a national prospective cohort study including women diagnosed with ovarian cancer from 2012 to 2015. Treatment information collected via medical records was used as the reference standard. Linked administrative data were obtained from national (Medicare Benefits Schedule, Pharmaceutical Benefits Scheme) and state/territory (hospital admitted patient data collections) data linkage units. The data were partitioned into training (60%, n = 413) and validation (40%, n = 271) datasets. Initial definitions were developed and further refined using the training set and based on clinical advice. The final definitions were assessed using the validation set. Sensitivity, specificity, negative predictive value, positive predictive value and kappa were calculated for receipt of treatment, whereas agreement was assessed for dates and continuous measures. Results: Sensitivity and specificity were high for receipt of chemotherapy (99%, 100%), cytoreductive surgery (97%, 100%), platinum-based chemotherapy (97%, 100%), taxane-based chemotherapy (98%, 88%), intra-peritoneal chemotherapy (93%, 99%) and whether chemotherapy was given in the adjuvant setting (100%, 90%). Agreement for treatment dates was high for surgery (exact agreement 90%, 97% ±7 days) and first chemotherapy (85%, 96% ±7 days). Agreement was moderately high for end of primary chemotherapy (72%, 82% ±7 days), number of chemotherapy cycles (65%, 89% ±1 cycle) and chemotherapy regimen (86%). Conclusions: Linked administrative data can provide accurate information on core aspects of ovarian cancer treatment when there are barriers to accessing patient medical records.Keywords
Funding Information
- National Health and Medical Research Council (GNT1025142, GNT1043134, GNT1120431)
- Australian Medical Research Futures Fund (MRF1200503)
This publication has 18 references indexed in Scilit:
- The burdensome logistics of data linkage in Australia – the example of a national registry for congenital heart diseaseAustralian Health Review, 2023
- Evaluating the impact of dose reductions and delays on progression-free survival in women with ovarian cancer treated with either three-weekly or dose-dense carboplatin and paclitaxel regimens in the national prospective OPAL cohort studyGynecologic Oncology, 2020
- A healthy lifestyle and survival among women with ovarian cancerInternational Journal of Cancer, 2020
- Validation studies of claims data in the Asia‐Pacific region: A comprehensive reviewPharmacoepidemiology and Drug Safety, 2018
- Validity of Administrative Databases in Comparison to Medical Charts for Breast Cancer Treatment DataJournal of Cancer Epidemiology, 2018
- The shift toward neo‐adjuvant chemotherapy and interval debulking surgery for management of advanced ovarian and related cancers in a population‐based setting: Impact on clinical outcomesAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2017
- Early initiation of chemotherapy following complete resection of advanced ovarian cancer associated with improved survival: NRG Oncology/Gynecologic Oncology Group studyAnnals of Oncology, 2015
- Treatment patterns among colorectal cancer patients in South Australia: a demonstration of the utility of population‐based data linkageJournal of Evaluation in Clinical Practice, 2014
- Validity of Eight Integrated Healthcare Delivery Organizations' Administrative Clinical Data to Capture Breast Cancer Chemotherapy ExposureCancer Epidemiology, Biomarkers & Prevention, 2012
- Development and use of reporting guidelines for assessing the quality of validation studies of health administrative dataJournal of Clinical Epidemiology, 2011